These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 368005)

  • 61. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The current sensitivity and resistance of the genus Proteus to each of 12 antibiotics. (The bacteriostatic and bacteriocidal action of carbenicillin)].
    Paredes L; Fernández M; Andrews E; Silva M
    Rev Med Chil; 1970 Jan; 98(1):5-10. PubMed ID: 4157376
    [No Abstract]   [Full Text] [Related]  

  • 63. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Colonial variation in Serratia marcescens together with antibiotic resistance.
    Ruhen RW; Wetherall FM
    Pathology; 1983 Jan; 15(1):65-6. PubMed ID: 6343980
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Letter: Serratia marcescens endocarditis.
    Sands M; Sanders CV
    Ann Intern Med; 1976 Sep; 85(3):397-8. PubMed ID: 786096
    [No Abstract]   [Full Text] [Related]  

  • 66. Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens.
    Miller MA; Chang CY; Tsang JC
    Antimicrob Agents Chemother; 1973 Jul; 4(1):66-8. PubMed ID: 4598846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relation of cell wall lipid content of Serratia marcescens to resistance to antimicrobial agents.
    Winshell EB; Neu HC
    Antimicrob Agents Chemother; 1974 Jul; 6(1):73-5. PubMed ID: 15828173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
    Sanders CC; Watanakunakorn C
    J Infect Dis; 1986 Mar; 153(3):617-9. PubMed ID: 3512733
    [No Abstract]   [Full Text] [Related]  

  • 69. The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.
    Greenfield S; Feingold DS
    J Infect Dis; 1970 May; 121(5):555-8. PubMed ID: 4316000
    [No Abstract]   [Full Text] [Related]  

  • 70. Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy.
    Wallace RJ; Wiss K; Curvey R; Vance PH; Steadham J
    Antimicrob Agents Chemother; 1983 Jan; 23(1):19-21. PubMed ID: 6830207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Properties of Serratia marcescens strains isolated in septic diseases of newborn infants].
    Abrikosova NIu; Kostiukova NN; Raginskia VP; Terekhov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):19-21. PubMed ID: 3911669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Umbelliprenin from Ferula persica roots inhibits the red pigment production in Serratia marcescens.
    Iranshahi M; Shahverdi AR; Mirjani R; Amin G; Shafiee A
    Z Naturforsch C J Biosci; 2004; 59(7-8):506-8. PubMed ID: 15813369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Astromicin-induced membrane damage in Serratia marcescens.
    Umeda A; Murata K; Amako K
    Antimicrob Agents Chemother; 1986 Sep; 30(3):398-402. PubMed ID: 3535663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sponsor-dependent drug resistance in B. subtilis reappears at high antibiotic concentrations.
    Dums F; Klingmüller W
    Naturwissenschaften; 1985 Jan; 72(1):37-9. PubMed ID: 3919318
    [No Abstract]   [Full Text] [Related]  

  • 75. Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens.
    Phadke SM; Lazarevic V; Bahr CC; Islam K; Stolz DB; Watkins S; Tencza SB; Vogel HJ; Montelaro RC; Mietzner TA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2041-5. PubMed ID: 12019137
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin.
    Thornton GF; Andriole VT
    J Infect Dis; 1969; 119(4):393-4. PubMed ID: 4892391
    [No Abstract]   [Full Text] [Related]  

  • 78. The combination of erythromycin and colistin against Serratia marcescens.
    Fothergill J; Smith JA
    J Antimicrob Chemother; 1981 Jun; 7(6):681. PubMed ID: 7019189
    [No Abstract]   [Full Text] [Related]  

  • 79. [Bactericidal activity of the complement and its synergistic effects with cephem antibiotics against Serratia marcescens].
    Kiyota H; Onodera S; Kishimoto K; Goto H; Machida T; Yokota T
    Nihon Hinyokika Gakkai Zasshi; 1988 May; 79(5):910-7. PubMed ID: 3070107
    [No Abstract]   [Full Text] [Related]  

  • 80. Antibiogram and lipid analysis of a pigmented strain of Serratia marcescens and its nonpigmented variants.
    Button GL; Miller MA; Tsang JC
    Antimicrob Agents Chemother; 1975 Feb; 7(2):219-22. PubMed ID: 1094951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.